The effect of zinc sulfate in the treatment of common warts
Phase 2
Recruiting
- Conditions
- Common wart.Viral warts
- Registration Number
- IRCT20190809044483N1
- Lead Sponsor
- Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
All patients with common warts
Exclusion Criteria
Patients under 12 years
Patients with immunodeficiency
Patients who have already received treatment for warts
Pregnancy
Breastfeeding
Facial warts
Genital warts
Warts around the nail
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measurement of wart lesion size. Timepoint: At base line and 2,4,6,8,12 weeks later. Method of measurement: Measurement of lesion size by physical examination.
- Secondary Outcome Measures
Name Time Method Hyperpimentation. Timepoint: At baseline (before intervention)and weeks 2,4,6,8,12. Method of measurement: By physical examination.;Hypopigmentation. Timepoint: At baseline (before intervention)and weeks 2, 4, 6, 8,12. Method of measurement: By physical examination.;Atrophic scar. Timepoint: At baseline (before intervention)and weeks 2, 4, 6, 8, 12. Method of measurement: By physical examination.